Syndax Pharmaceuticals COO Michael Metzger's 2019 pay jumps 77% to $2.7M
Syndax Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
Syndax Pharmaceuticals reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, three executives at Syndax Pharmaceuticals received on average a compensation package of $1.7M, a 10% increase compared to previous year.
Average pay of disclosed executives at Syndax Pharmaceuticals
Michael A. Metzger, Chief Operating Officer, received $2.7M in total, which increased by 77% compared to 2018. 71% of Metzger's compensation, or $1.9M, was in option awards. Metzger also received $252K in non-equity incentive plan, $540K in salary, as well as $3K in other compensation.
Briggs W. Morrison, Chief Executive Officer, received a compensation package of $1.6M, which decreased by 23% compared to previous year. 47% of the compensation package, or $764K, was in option awards.
Michael L. Meyers, Chief Medical Officer, earned $818K in 2019, a 22% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2020.